Faster healing, less pain

Propovir heals cold sores faster*

Propovir is clinically proven to reduce healing time and pain associated with cold sores.*

Clinical Study 1

Reference: Szmeja et al., Otolaryng Pol, 41(3): 183 – 188, 1987.

Propovir shortens healing time associated with cold sores

The healing time in patients using propovir was up to 4 days less than patients using placebo.

Randomised double-blind clinical study in patients with herpes labialis.
Assessed the clinical usefulness of 2% propolis ointment ACF in the treatment of herpes labialis.

  • Total of 50 patients
  • 25 in the placebo group
  • 25 in the propovir group
  • Treatment was applied 4 times daily until healed

The healing time in patients using propovir was up to 4 days less than patients using placebo.

Clinical Study 2

Reference: Compared to no treatment. Hoheisel O, Journal of Clinical Research 2001; 4: 65-75. Financed by Hela Pharma AB.

Propovir reduces healing time and pain associated with cold sores

Patients using propovir experienced less pain, and felt no pain by day 7, while 22.9% patients in the placebo group were still reporting pain.

The healing time of patients using propovir was 3.5 days less than patients using placebo.

Double-blind placebo-controlled clinical study in patients with herpes labialis.
Assessed the effects of 3% propolis ointment ACF application in the treatment of cold sores.

  • Total of 68 patients
  • 35 in the placebo group
  • 33 in the propovir group
  • Treatment was applied 5 times daily until healed
  • Patients were instructed to fill a cold sore diary and to report stage of the cold sore and
    degree of pain
  • Healing time and time to loss of pain were evaluated
  • Patients were asked to express their opinion on the treatment at the end of the study

The healing time in patients using propovir was up to 3.5 days less than patients using placebo.

Patients using propovir experienced less pain, and felt no pain by day 7, while 22.9% patients in the placebo group were still reporting pain.

1. Compared to placebo. Hoheisel O, Journal of Clinical Research 2001. Financed by Hela Pharma AB.
2. Szmeja et al., Otolaryng Pol, 41(3): 183 – 188, 1987.

.

color
https://www.propovir.com.au/wp-content/themes/imperio/
https://www.propovir.com.au/
#f2cd41
style2
paged
Loading posts...
/var/www/vhosts/propovir.com.au/httpdocs/
#
off
none
loading
#
Sort Gallery
on
off
off
off